Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Research from University of London, Imperial College has provided new information about life sciences
March 11th, 2009
"Host defenses, while effecting viral clearance, contribute substantially to inflammation and disease. This double action is a substantial obstacle to the development of safe and effective vaccines against many agents, particularly respiratory syncytial virus (RSV)," scientists in London, the United Kingdom report. "RSV is a common cold virus and the major cause of infantile bronchiotitis worldwide. The role of alpha beta T cells in RSV-driven immunopathology is well studied, but little is known about the role of ''unconventional'' T cells. During primary RSV challenge of BALB/c mice, some V gamma 7(+) gamma delta T cells were present; however, immunization with a live...
Source: Vaccine Weekly (2009-03-11)
|
